Fundz

Actinium Pharmaceuticals

New York, New York, United States · Biotechnology, Health Care, Therapeutics

Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT

Key facts

Headquarters
New York, New York, United States
Employees
31
Industries
Biotechnology, Health Care, Therapeutics
Status
Public (ATNM)
Website
www.actiniumpharma.com
LinkedIn
Company page

Recent activity at Actinium Pharmaceuticals

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Leadership

  • Matt David, M.D., Chief Financial Officer
  • Matt David, Chief Financial Officer
  • Sandesh Seth, Chairman & Chief Executive Officer
  • Steffen Heeger, Chief Medical Officer
  • Lynn Bodarky, Chief Business Officer

Verified email and direct lines for Actinium Pharmaceuticals’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Actinium Pharmaceuticals files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Oct 2027.

Companies similar to Actinium Pharmaceuticals

About Actinium Pharmaceuticals: questions and answers

What does Actinium Pharmaceuticals do?

Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT

Where is Actinium Pharmaceuticals headquartered?

Actinium Pharmaceuticals is headquartered in New York, New York, United States.

How many employees does Actinium Pharmaceuticals have?

Actinium Pharmaceuticals has about 31 employees.

Who leads Actinium Pharmaceuticals?

Sandesh Seth is a Chairman & Chief Executive Officer at Actinium Pharmaceuticals.

What is the latest news on Actinium Pharmaceuticals?

On Oct 15, 2026, Actinium Pharmaceuticals Appoints Matt David as Chief Financial Officer

Is Actinium Pharmaceuticals a public company?

Yes. Actinium Pharmaceuticals is publicly traded under the ticker ATNM.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Actinium Pharmaceuticals across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.